-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Grants Breakthrough Therapy Designation to Incyte's INCA033989 for CALR-Mutant Essential Thrombocythemia

路透·12/08/2025 21:33:41

登录查看新闻详情